00809 GLOBAL BIO-CHEM
- 0.095
- -0.009-8.65%
GLOBAL BIO-CHEM News
Global Corn Starch Market Analysis and Competitive Landscape Report 2024-2032 Featuring Cargill, Ingredion, ADM, Tate & Lyle, Associated British Foods, Tereos, Sudzucker, & Global Bio-Chem Technology - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Corn Starch Market Report by Type, Form, End-Use, Region and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.It is projected
大成生化科技：年報2023
Global Bio-chem Technology Returns to Profit in 2023 on Debt Restructuring, Asset Disposal
Global Bio-chem Technology Group Company (HKG:0809) swung to a profit in 2023, driven by one-off gains from its debt restructuring and asset disposal, according to a March 28 release. Attributable pro
Dacheng Biochemical Technology (00809) Announces 2023 Annual Results Profit attributable to shareholders of HK$4.225 billion, turning a year-on-year loss into profit
Dacheng Biochemical Technology (00809) announced its annual results for the year ended December 31, 2023. The group achieved...
GLOBAL BIO-CHEM: ANNOUNCEMENT OF THE FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Dacheng Biochemical Technology (00809.HK) plans to hold a board meeting on March 28 to approve annual results
Glonghui, March 18, 丨 Dacheng Biochemical Technology (00809.HK) announced that the board of directors meeting will be held on March 28, 2024 to review and approve the annual results of the company and its subsidiaries for the year ended 31 December 2023 and consider the payment of a final dividend (if any).
Global Bio-chem Technology Expects Up to HK$4 Billion Gains in 2023; Shares Soar 10%
Global Bio-chem Technology Group (HKG:0809) expects to record a net gain of between HK$3.60 billion and HK$4 billion for 2023. The forecast was attributed to gains accumulated from debt restructuring
Announcement Highlights: NetEase Q4 net revenue increased 7% year-on-year to 27.14 billion yuan; Yuexiu Real Estate acquired land for 1,414 billion yuan
NetEase Cloud Music's revenue in 2023 was 7.87 billion yuan, turning a loss into a profit for the first time, and gross margin rose to 26.7%; Pacific Shipping had a turnover of US$2,297 billion in 2023, a year-on-year decrease of 30.02%.
Dacheng Biochemical Technology (00809) is expected to achieve annual net profit of HK$3.6 billion to HK$4 billion, turning a year-on-year loss into profit
Dacheng Biochemical Technology (00809) issued an announcement. Regarding the Group's continued operation and discontinued business, the Group expects to...
大成生化科技：內幕消息 盈利預告
Demand for spring farming led to a rebound in the urea market and repair profit margins, but far from the previous year|Industry News
① Spring cultivation and preparation for cultivation have been carried out one after another. Many urea manufacturers, such as Hualu Hengsheng, Sichuan Meifeng, Liuguo Chemical, and Lutianhua, raised the ex-factory price of urea products by about 50 yuan to 60 yuan/ton, and the price increase of urea prices was nearly 8% in the past month; ② Under high supply, urea prices were only 80% of the same period last year, and the profit margin was less than the same period last year.
Ministry of Finance: The total profit of state-owned enterprises in 2023 was 4633.28 billion yuan, up 7.4% year-on-year
From January to December, the main efficiency indicators of state-owned and state-owned enterprises across the country continued to grow steadily, and the upward trend was further consolidated.
Global Bio-Chem Co-Founders Close Takeover Bid for Global Sweeteners
Global Sweeteners Holdings or GSH (HKG:3889) announced the close of the mandatory unconditional cash offer by CCB International and China Galaxy International on behalf of the joint offerors. The join
Global Bio-Chem Technology Units Enter Into 5 Billion Yuan Debt Restructuring Deals
Global Bio-Chem Technology Group (HKG:0809) subsidiaries entered into debt restructuring plans with Nongtou, or Jilin Agricultural Investment Group worth 5.08 billion yuan for three years ending Dec.
Global Bio-Chem Technology Shareholders to Vote Dec. 31 on Proposed Issue of Convertible Preference Shares to 2 Parties
Shareholders of Global Bio-Chem Technology Group (HKG:0809) will meet on Dec. 31 to vote on the proposed issue of convertible preference shares to two equity investment companies at HK$0.10 apiece. Th
Global Bio-Chem Technology's Chairman Steps Down; Replacement Named
Global Bio-Chem Technology Group (HKG:0809) said Yang Jian has resigned as an executive director of the firm and will cease to be the chairman of the board effective today, Dec. 11. The firm has appoi
Dacheng Biochemical Technology (00809.HK): Wang Cheng appointed as Executive Director and Chairman of the Board
Gelonghui December 11丨Dacheng Biochemical Technology (00809.HK) announced that, from December 11, 2023: (1) Yang Jian has resigned as the executive director and no longer serves as the chairman of the board of directors, the chairman of the nomination committee, the executive committee, the remuneration committee and the corporate governance committee, and the authorized representative under the listing rules; and (2) Wang Cheng has been appointed and appointed as the executive director, chairman of the board of directors, chairman of the nomination committee, and each member of the executive committee, remuneration committee and corporate governance committee, and authorized representative under the listing rules.
Dacheng Biochemical Technology (00809.HK) entered into a subscription agreement to propose an increase in authorized share capital to HK$6 billion
Gelonghui November 30丨Dacheng Biochemical Technology (00809.HK) announced that on November 30, 2023, Jilin Yuanheng and Jilin Liheng (as the subscribing party) signed a subscription agreement with the company (as the issuer). According to this, (i) Jilin Yuanheng conditionally agreed to use the full Jilin Yuanheng subscription amount (that is, RMB 250 million) to subscribe to the number of Yuanheng convertible preferred shares that can be issued to Jilin Yuanheng; and (ii) Jilin Liheng conditionally agreed to fully use the Jilin Henry subscription plan (i.e. RMB 250 million) (i.e. RMB 1.33 billion) Subscribe to Liheng convertible shares that can be issued to Jilin Liheng Number of preferred shares, subscription price per share
Dacheng Biochemical Technology (00809) and Agricultural Investment signed a 2023 main supply agreement to purchase corn pellets
Dacheng Biochemical Technology (00809) issued an announcement. On November 1, 2023, the company and Agricultural Investment signed an agreement on agriculture...
Global Bio-Chem's Shares Drop on Lingering GSH Sale Deal
Shares of Global Bio-Chem Technology Group (HKG:0809) fell some 7% in recent trade, a day after the firm said it has extended the time frame for the planned disposal of Global Sweeteners Holdings (GSH
Analysis
Price Target
No Data
